Results 1 to 10 of about 7,071,866 (358)

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but whether empagliflozin also improves clinical outcomes when initiated in ...
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly   +2 more sources

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

European Heart Journal, 2021
An engaging session on the newly revised European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) was conducted on the first day of the 2021 ESC virtual congress.
T. McDonagh, M. Metra, M. Adamo, R. S. Gardner, A. Baumbach, Michael Böhm, H. Burri, J. Butler, J. Čelutkienė, O. Chioncel, John G. Cleland, A. Coats, M. Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W. Hoes, Tiny Jaarsma, E. A. Jankowska, M. Lainščak, C. S. Lam, A. Lyon, J. J. McMurray, A. Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, G. Rosano, F. Ruschitzka, Anne Kathrine Skibelund   +30 more
semanticscholar   +2 more sources

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients

Transplantation Direct, 2022
Background. A pulmonary capillary wedge pressure (PCWP) >18 mm Hg following volume load has been proposed as a partition value for the detection of heart failure with preserved ejection fraction. As hemodynamic changes in filling pressures (FP) have been
Monika Kobediona, MD, Jozef Bartunek, MD, PhD, Leen Delrue, PhD, Frederik Van Durme, MD, Chirik Wah Lau, MD, Ana Moya, PhD, Sofie Verstreken, MD, Ward Heggermont, MD, PhD, Riet Dierckx, MD, Marc Goethals, MD, Marc Vanderheyden, MD   +10 more
doaj   +1 more source

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation, 2022
AIM The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart ...
P. Heidenreich, B. Bozkurt, D. Aguilar, L. Allen, Joni J. Byun, Monica Colvin, A. Deswal, M. Drazner, S. Dunlay, Linda R. Evers, J. Fang, S. Fedson, G. Fonarow, S. Hayek, Adrian F. Hernandez, P. Khazanie, M. Kittleson, Christopher S. Lee, M. Link, C. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, L. Stevenson, O. Vardeny, A. Vest, C. Yancy   +25 more
semanticscholar   +1 more source

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

New England Journal of Medicine, 2021
BACKGROUND Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction ...
S. Anker, J. Butler, G. Filippatos, J. Ferreira, E. Bocchi, M. Böhm, H. Brunner-la Rocca, D. Choi, V. Chopra, E. Chuquiure-Valenzuela, N. Giannetti, J. Gómez-Mesa, S. Janssens, J. Januzzi, J. González-Juanatey, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, M. Senni, D. Sim, J. Špinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu, Jian Zhang, P. Carson, Carolyn S. P. Lam, N. Marx, C. Zeller, N. Sattar, W. Jamal, S. Schnaidt, J. Schnee, M. Brueckmann, S. Pocock, F. Zannad, M. Packer   +40 more
semanticscholar   +1 more source

Selection of Comprehensive Assessment Categories Based on the International Classification of Functioning, Disability, and Health for Elderly Patients with Heart Failure: A Delphi Survey among Registered Instructors of Cardiac Rehabilitation

Occupational Therapy International, 2021
The development of a comprehensive assessment tool based on the International Classification of Functioning, Disability, and Health (ICF) for elderly patients with heart failure is urgently required.
Shigehito Shiota, Makiko Naka, Toshiro Kitagawa, Takayuki Hidaka, Naoki Mio, Kana Kanai, Mariko Mochizuki, Hiroaki Kimura, Yasuki Kihara   +8 more
doaj   +1 more source

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

European Journal of Heart Failure, 2022
Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P. Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor Aboyans (France), Stamatis Adamopoulos (Greece), Stefan D.
T. McDonagh, M. Metra, M. Adamo, R. Gardner, A. Baumbach, M. Böhm, H. Burri, J. Butler, J. Čelutkienė, O. Chioncel, J. Cleland, A. Coats, M. Crespo-Leiro, D. Farmakis, M. Gilard, S. Heymans, A. Hoes, T. Jaarsma, E. Jankowska, M. Lainščak, C. Lam, A. Lyon, J. McMurray, A. Mebazaa, R. Mindham, C. Muneretto, Massimo Francesco Piepoli, S. Price, G. Rosano, F. Ruschitzka, Anne Kathrine Skibelund   +30 more
semanticscholar   +1 more source

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

New England Journal of Medicine, 2022
BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less.
S. Solomon, J. McMurray, B. Claggett, R. D. de Boer, D. DeMets, Adrian F. Hernandez, S. Inzucchi, M. Kosiborod, C. Lam, F. Martinez, Sanjiv J. Shah, Akshay S. Desai, P. Jhund, J. Bělohlávek, C. Chiang, C. Borleffs, J. Comín-Colet, D. Dobreanu, J. Drożdż, J. Fang, M. Alcocer-Gamba, Waleed Al habeeb, Yaling Han, Jose Walter Cabrera Honorio, S. Janssens, T. Katova, M. Kitakaze, B. Merkely, E. O’Meara, J. Saraiva, S. Tereshchenko, J. Thierer, M. Vaduganathan, O. Vardeny, S. Verma, V. Pham, U. Wilderäng, Natalia Zaozerska, E. Bachus, D. Lindholm, Magnus Petersson, A. Langkilde   +41 more
semanticscholar   +1 more source

Moderate Aortic Stenosis in Patients With Heart Failure

Korean Circulation Journal, 2022
Author's summary Moderate aortic stenosis with concomitant heart failure portends a significantly worse prognosis in both preserved and reduced left ventricular ejection fraction.
V. Truong, John Ernst, Akhil Pallerla, Amitesh Verma, C. Bartone, C. Palmer, E. Chung   +6 more
semanticscholar   +1 more source

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

New England Journal of Medicine, 2020
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.
M. Packer, S. Anker, J. Butler, G. Filippatos, S. Pocock, P. Carson, J. Januzzi, S. Verma, H. Tsutsui, M. Brueckmann, W. Jamal, K. Kimura, J. Schnee, C. Zeller, D. Cotton, E. Bocchi, M. Böhm, D. Choi, V. Chopra, E. Chuquiure, N. Giannetti, S. Janssens, Jian Zhang, J. G. González Juanatey, S. Kaul, H. Brunner-la Rocca, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, N. Sattar, M. Senni, M. Séronde, J. Špinar, I. Squire, S. Taddei, C. Wanner, F. Zannad   +38 more
semanticscholar   +1 more source